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Background: Pancreatitis induced by hypertriglyceridemia (HTG) has gained much attention. However, very limited
numbers of studies have focused on the clinical significance of TG elevation in non-HTG induced pancreatitis, such
as acute biliary pancreatitis (ABP). This study aimed to study the clinical significances of triglyceride (TG) elevation in
patients with ABP.
Methods: We retrospectively analyzed a total of 426 ABP cases in our research center. According to the highest TG
level within 72 h of disease onset, the patients were divided into a normal TG group and an elevated TG group.
We analyzed the differences between the two groups of patients in aspects such as general information, disease
severity, APACHE II (acute physiology and chronic health evaluation II) and Ranson scores, inflammatory cytokines,
complications and prognosis.
Results: Compared with the normal TG group, patients in the elevated TG group showed a significantly higher
body mass index and were significantly younger. TG elevation at the early stage of ABP was associated with higher
risk of severe pancreatitis and organ failures, especially respiratory failure. For patients with severe pancreatitis, those
with elevated TG levels were more likely to have a larger area of necrosis, and higher incidence of pancreatic
abscess as well as higher mortality (17.78% versus 9.80%, P < 0.05).
Conclusions: In ABP patients, TG elevation might participate in the aggravation of pancreatitis and the occurrence
of systemic or local complications. Thus, the TG level may serve as an important indicator to determine the
prognosis of patients with ABP.
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Acute pancreatitis (AP) is a life-threatening inflamma-
tory disease involving the pancreas as well as peripan-
creatic and even distant organs [1]. The main causes of
AP include biliary tract disease, alcohol abuse, congenital
anomaly, drugs, etc. [2]. In recent years, the relationship
between hypertriglyceridemia (HTG) and AP has re-
ceived widespread attention from scholars, and it is gen-
erally believed that blood triglyceride (TG) levels greater
than 11.3 mmol/L can directly induce AP [3,4]. However,
HTG-induced AP is uncommon, accounting for only
1-4% of AP cases. On the other hand, HTG is com-
monly present at the early stage of non-HTG-induced* Correspondence: whjtlj1251@163.com; tfz3006101@163.com
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unless otherwise stated.AP, such as acute biliary pancreatitis (ABP), and its
clinical significance remains unclear.
It has been reported that more than 50% of non-HTG-
induced AP patients demonstrate mild-to-moderate TG
elevation [5]. However, the relationship between the ele-
vated TG level and severity of non-HTG-induced AP is
not well documented. Some studies reported that when
non-HTG-induced AP was accompanied by TG elevation,
the disease course of AP shows a trend for aggravation;
in particular, if the serum TG level is reduced under
5.65 mmol/L, the disease condition will be gradually sta-
bilized and improved [6-8]. However, some other studies
showed that an increased TG level might just represent a
symptom associated with AP, and there is no significant
relationship between an elevated TG level and the severity
and prognosis of AP patients [9]. This discrepancy may be
due to the fact that the AP cases included in these studiesThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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different roles in AP cases induced by different causes.
Therefore, investigating the clinical significance of an
elevated TG level in AP induced by a single homoge-
neous cause could more accurately illustrate the effects
of mild-to-moderate HTG on the severity and prognosis
of AP patients. As acute biliary pancreatitis (ABP) remains
the main type of AP in China and many other countries,
the current study focused on the clinical significance of




This study retrospectively analyzed 426 ABP cases that
were treated in our hospital. The diagnosis and classifi-
cation of the severity of AP were performed according
to the 2012 revision of the Atlanta Classification [10]. The
diagnosis of ABP was based on the standards proposed in
the literature with the following minor amendments [11]:
1) confirmed diagnosis of AP; 2) no history of hyperlipid-
emia or alcohol abuse; 3) abdominal ultrasonography
(AUS), computed tomography (CT), magnetic resonance
cholangiopancreatography (MRCP), and endoscopic ultra-
sound (EUS) detection of gallstones or biliary sludge,
or laboratory tests showing two of the following items:
ALT >75U/L, ALP >125 U/L, and TBIL >2.3 mg/dl. This
study was performed according to the principles of the
Declaration of Helsinki (modified 2000) and was approved
by the ethics committee of Chengdu Military General
Hospital (No. 2013037).
Treatment protocols
At the outset, all patients were treated in a conservative
manner, with fluid resuscitation and antibiotics, as de-
scribed in the literature [12,13]. Endoscopic retrograde
cholangiopancreatography (ERCP) and endoscopic sphinc-
terotomy (EST) were performed in patients with jaundice
and cholangitis. Percutaneous catheter drainage (PCD)
were carried out to eliminate the debris and collections in
the (peri)pancreas, similar to other reports [14]. The num-
ber and size of the catheters were determined by the size,
viscosity, and location of the debris and collections. In ac-
cordance with widely accepted consensus [15], if there
was no clinical improvement or if ongoing necrosis with
bowel complications was present, open necrosectomy




According to the highest TG level within 72 h of dis-
ease onset, the patients were divided into a normalTG group (<1.88 mmol/L) and an elevated TG group
(≥1.88 mmol/L).Data collection
In addition to the collection of general information in-
cluding sex, age, body mass index (index), etc., we spe-
cially analyzed differences between the normal TG group
and the elevated TG group in aspects such as pancreatitis
severity score, incidence of systemic complications, inci-
dence of local complications, mortality, days in hospital
and intensive care unit and care cost. Differences in levels
of inflammatory cytokines within 72 h of disease onset—
C-reaction protein (CRP), interleukin 6 (IL-6), IL-10,
tumor necrosis factor-alpha (TNF-α) —between the two
groups were also analyzed. Initial contrast-enhanced com-
puted tomography was performed within the first week of
the onset of disease and repeated depending on the indi-
cation. The images obtained were double-checked by two
experienced radiologists. Meanwhile, extent of necrosis
were measured and classified into three grades, <30%, 30-
50% and >50%, according to Balthazar classification. Acute
physiology and chronic health evaluation II (APACHE II)
score and CTSI were calculated for each patient at the
time of admission and serially calculated before and after
each type of intervention.Definition and criteria
The classification of AP severity was based on the 2012
revision of the Atlanta Classification, and the Ranson score
and APACHE II (acute physiology and chronic health
evaluation II) score were calculated within 24 ~ 48 h after
patient admission.
The diagnostic criteria for systemic complications of
AP were as follows: shock, with systolic blood pres-
sure ≤80 mmHg and a duration of 15 min; respiratory
failure, with PaO2 ≤ 60 mmHg; renal failure, with serum
creatinine >176.8 μmol/L; coagulation disorders, with pro-
thrombin time (PT) less than 70% that of normal people
and/or partial thromboplastin time (PTT) > 45 s; sepsis,
with a body temperature (T) > 38.5°C, white blood cell
(WBC) count >6.0 × 109/L, base excess ≤ 4 μmol/L, a dur-
ation of 48 h, and positive blood/ aspirate bacterial culture;
systemic response syndrome, with T >38.5°C or <36°C,
WBC count >12.0 × 109/L or <4.0 × 109/L, pulse >90 beats/
min, and respiratory rate >20 breaths/min or PCO2 <
32 mmHg; upper gastrointestinal bleeding; and pan-
creatic encephalopathy. Local complications of AP in-
cluded pancreatic necrosis, inanimate pancreatic tissue,
or peripancreatic fat as revealed by enhanced CT and
pancreatic pseudocyst, with liquid accumulation wrapped
in a complete and non-epithelial envelope and enclosed
pancreatic secretions, granulation tissue, and fibrous
tissue.
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The statistical analysis was carried out using SPSS ver-
sion 16.0 for Windows (SPSS Inc., Chicago, IL). Normality
of data was determined by Kolmogorov–Smirnov tests of
normality. Data were expressed as mean ± standard devi-
ation for normally distributed data and median and inter-
quartile range for non-normally distributed data. For
normally distributed data, variables were compared using
Student’s t test for two groups. For skewed data, the
Mann–Whitney test was used. Qualitative or categor-
ical variables were described as frequencies and propor-
tions. Proportional variables were compared using the χ2
test or Fisher’s exact test. All statistical tests were two-
tailed and performed at a significance level of P < 0.05.
Results
Comparison of general information of patients
There were 426 ABP cases included, of which 289 (67.84%)
were assigned to the normal TG group and 137 (32.16%)
to the elevated TG group. The mean levels of TG in the
two groups were 1.21 mmol/L and 6.52 mmol/L, respect-
ively. This cohort included 188 male and 238 female pa-
tients, and the male/female ratio of the elevated TG group
was significantly higher than that of the normal TG group
(72/65 versus 116/173, p < 0.05). In addition, the age of
the patients in the elevated TG group was significantly
lower than that in the normal TG group (46.35 ± 7.26 ver-
sus 54.89 ± 7.84, p < 0.05), while the body mass index
(BMI) of the elevated TG group was significantly higher
than that of the normal TG group (28.35 ± 5.13 versus
22.57 ± 4.42, p < 0.01), Table 1. Meanwhile, the frequencies
of manifestation of cholangitis between the two groups
were not significantly different, 22.15% (64/289) versus
23.36% (32/137). These results showed that younger male
ABP patients with a higher BMI were more likely to be
complicated with TG elevation.Table 1 The characteristics of ABP patients enrolled in this st
characteristic Norm
Number of patients 289
Demographic data
Age (mean ± SD) 54.89
Male/female 116/1
BMI 22.57
Referral after onset of symptoms (hours) (mean ± SD) 26.8 ±
TG level (mmol/L) 1.21 ±
Manifestation of cholangitis (%) 22.15
Medical economics (median ± interquartile range)
Days in hospital 34.7 ±
Days in intensive care unit (ICU) 5.2 ±
Total cost during hospitalization (Dollars) 5646
TG, triglyceride; BMI, body mass index. *Significant difference.Relationship between TG level and ABP severity
The total incidence rate of moderately severe acute pan-
creatitis (MSAP) and severe acute pancreatitis (SAP) in
this study group was 22.54% (96/426); in particular, SAP
and MSAP patients accounted for 32.85% (45/137) of the
cases in elevated TG group, and this rate was significantly
higher than that in the normal TG group (p < 0.05). La-
boratory detection showed that the CRP level in elevated
TG group was remarkably higher than that in normal TG
group (p < 0.05). Meanwhile, patients in the elevated TG
group had APACHE II scores and Ranson scores that
were significantly higher than those of patients in the nor-
mal TG group (p values were <0.01 and <0.05, respect-
ively), Table 2. Correlation analysis showed that TG levels
and APACHE II scores were significantly correlated (p <
0.05, R = 0.665) in patients in the elevated TG group,
whereas TG levels were not significantly correlated with
the Ranson score. These results suggest that elevated TG
levels in the early phase of ABP may be involved in the
progress of the disease.
Involvement of TG elevation in the occurrence of
systemic complications in severe ABP patients
With regard to the severe cases (including MSAP and
SAP), the incidence of systemic organ failure in elevated
TG group (33.33%, 17/51) was significantly higher than
that in the normal TG group (46.67%, 21/45), p < 0.05),
Table 3. Statistical analysis showed that severe ABP pa-
tients with elevated TG levels had a significantly increased
risk of organ failures involving single organ failure. Among
patients with moderate-severe degrees of severe pancrea-
titis, the incidence of respiratory failure was significantly
higher in the elevated TG group than the normal TG
group (28.89% (13/45) versus 13.73% (7/51), p < 0.05).
However, these two groups did not show significant differ-
ences in the incidence rates of renal failure, circulatoryudy
al TG group Elevated TG group P value
137
± 7.84 46.35 ± 7.26 0.011*
73 72/65 0.027*
± 4.42 28.35 ± 5.13 0.001*
16.8 24.5 ± 15.2 0.402
0.56 6.52 ± 1.52 0.001*
% (64/289) 23.36% (32/137) 0.435
16.42 39.5 ± 18.54 0.375
2.36 6.4 ± 3.46 0.562
.1 ± 1432.32 6103.2 ± 2140.29 0.781







Number of patients 289 137
Severity classification
MAP 238 (82.35%) 94 (68.61%) 0.157
MSAP 32 (11.07%) 28 (20.44%) 0.021*
SAP 19 (6.57%) 17 (12.41%) 0.015*
Laboratory parameters
C.reaction protein (CRP) (mg/L) 36.2 ± 15.33 61.2 ± 18.41 0.038*
IL-6 (pg/L) 54.5 ± 20.41 62.6 ± 22.42 0.241
IL-10 (pg/L) 30.6 ± 17.48 35.1 ± 18.59 0.672
TNF-α (pg/L) 8.2 ± 3.53 9.8 ± 3.77 0.521
Severity scores
APACHIIscore (mean ± SD) 6.26 ± 3.48 10.11 ± 3.62 0.007*
Ranson score (mean ± SD) 1.68 ± 0.79 2.34 ± 0.93 0.042*
Marshall score (mean ± SD) 2.1 ± 0.57 2.6 ± 0.68 0.142
TG, triglyceride; MAP, mild acute pancreatitis; MSAP, moderately severe acute
pancreatitis; SAP, severe acute pancreatitis; APACHE II, acute physiology and
chronic health evaluation II. *Significant difference.
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failure (p > 0.05). These results suggest that ABP patients
with elevated TG levels are more likely to develop organ
failure, particularly respiratory failure.
Effect of TG elevation on the development of local
complications in patients with ABP
Among patients with moderate-severe degrees of severe
ABP, 55.56% of patients with elevated TG levels had
pancreatic necrosis, and 50.98% of patients with normal
TG had pancreatic necrosis, with no significant difference
between these two groups. However, patients with ele-







Number of patients 51 45
Total organ failure 17 (33.33%) 21 (46.67%) 0.036*
Single 11 (21.57%) 15 (33.33%) 0.047*
Multiple 6 (11.76%) 6 (13.33%) 0.761
Respiration 7 (13.73%) 13 (28.89%) 0.022*
Circulation 5 (9.80%) 3 (6.67%) 0.535
Kidney 6 (11.76%) 5 (11.11%) 0.882
Coagulation 4 (7.84%) 3 (6.67%) 0.682
Other organ or system 4 (7.84%) 3 (6.67%) 0.682
TG, triglyceride; MSAP, moderately severe acute pancreatitis; SAP, severe acute
pancreatitis. *Significant difference.of developing necrosis over a relatively large area (with a
necrotic area greater than 30%) and a higher incidence of
pancreatic abscess compared to patients with normal TG
levels, Table 4. For patients with moderate-severe degrees
of severe ABP, there was no significant difference in the
incidence rates of pseudocysts between patients with ele-
vated TG and patients with normal TG levels. These re-
sults suggest that although TG elevation did not increase
the total incidence of pancreatic necrosis in ABP patients,
TG elevation may increase the scope and extent of pan-
creatic necrosis once necrosis occurs.
Association of TG level with treatments and prognosis of
ABP patients
All mild ABP patients were treated in a conservative man-
ner and were discharged after rehabilitation. There were
41.87 % of mild ABP patients (139/332) underwent ERCP/
EST, and no significant difference was observed between
normal TG group and elevated TG group. Besides ERCP/
EST,PCD and open necrosectomy were also performed in
some of patients with moderate or severe ABP. For pa-
tients with MSAP/SAP, although the frequencies of ERCP/
EST were not significantly different between normal TG
group and elevated TG group (47.06% (24/51) versus
46.67% (21/45)), more patients in elevated TG group
underwent PCD and open necrosectomy, Table 5. The
mortality rate of severe ABP patients with elevated TG
was 17.78% (8/45), whereas that of severe ABP patients
with normal serum TG was 9.80% (5/51); the difference
between the two groups was significant (p < 0.05). The pa-
tients were followed for 1 year, and we found no signifi-
cant differences in the recurrence rate and life quality of
patients after discharge. These results showed that TG ele-
vation may be a manifestation indicating poor prognosis
in patients with ABP.
Discussion
In recent years, the relationship between HTG and AP







Number of patients 51 45
Incidence of necrosis 34 (66.67%) 36 (80.00%) 0.253
Maximum extent of necrosis
Less than 30% 18 (35.29%) 12 (26.67 %) 0.137
30% ~ 50% 10 (19.61 %) 15 (33.33%) 0.027*
More than 50% 6 (11.76 %) 9 (20.00%) 0.002*
Pancreatic abscess 4 (7.84 %) 8 (17.78%) 0.001*
Pseudocyst 6 (11.76 %) 5 (11.11%) 0.683
*Significant difference.







Number of patients 51 45
ERCP or EST 24 (47.06%) 21 (46.67%) 0.566
PCD 20 (39.12%) 27 (60.00%) 0.033*
Open necrosectomy 3 (5.88%) 9 (13.33%) 0.037*
mortality 5 (9.80%) 8 (17.78%) 0.011*
recurrence rate within 1 year 10 (19.61%) 11 (24.44 %) 0.372
ERCP, Endoscopic retrograde cholangiopancreatography; and EST, endoscopic
sphincterotomy; PCD, Percutaneous catheter drainage. *Significant difference.
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can directly induce AP. However, despite the increasing in-
cidence of AP induced by HTG, this type of AP is not the
major type observed in clinical practice. The more com-
mon clinical situation is that non-HTG-induced AP pa-
tients were complicated with TG elevation, and it has been
reported in the literature that approximately 50% of non-
HTG-induced AP patients demonstrate mild-moderate TG
elevation. However, there have been only limited numbers
of studies on the significance of TG elevation in non-HTG
induced pancreatitis, such as acute biliary pancreatitis
(ABP), and the results were inconsistent.
It also remains controversial whether TG elevation is
an associated etiological factor or a concomitant symp-
tom in non-HTG induced AP patients. In alcoholic pan-
creatitis, alcohol can directly affect the metabolism of
TG, causing elevated TG levels, and is therefore directly
involved in the occurrence of pancreatitis. Thus, an ele-
vated TG level can be seen as an associated etiological
factor of alcoholic pancreatitis [16], whereas it may be
considered as concurrent symptom of biliary pancreatitis
[17]. In addition, the relationships between TG elevation
and the severity and prognosis of AP, as reported in the
literature, are also inconsistent. For example, studies have
reported that when AP induced by non-HTG causes is
complicated with TG elevation, the disease course of AP
shows a trend for aggravation [7,8]. However, other stud-
ies show that an increased TG level may only represent a
symptom associated with AP, as there is no significant re-
lationship between TG level and the severity and progno-
sis of AP patients [9]. The presence of these controversies
is likely due to the analysis of different compositions of
AP patient, including patients with biliary AP, alcoholic
AP, cryptogenic AP, and AP due to other factors, as HTG
is known to play different roles in AP caused by different
factors.
Therefore, the study of the clinical significance of an
elevated TG level in AP due to a single etiological factor
could accurately illustrate the effects of mild-moderate
HTG on AP disease condition and prognosis. Becausebiliary tract disease is a major cause of AP in China and
other Eastern countries, we chose to study the effects of
TG elevation on the disease condition and prognosis of
patients with ABP. When selecting cases, we excluded
patients with a history of hyperlipidemia and alcoholism,
aiming to exclude cases with elevated TG levels before the
onset of pancreatitis. During the occurrence of AP, due
to the body’s stress response, serum catecholamine and
glucagon levels, as well as lipase activity, are increased,
leading to accelerated break down of fat tissue and the
subsequent release of TG and increase in serum lipid con-
centrations [18,19]. In this study group, the incidence of
SAP in ABP patients associated with elevated TG was sig-
nificantly higher compared to that in patients without ele-
vated TG; in addition, ABP patients with elevated TG
levels also showed more severe pancreatic necrosis. These
results may be due to the fact that elevated TG might lead
to increased blood viscosity, which further promotes
blood circulation disorders of the pancreas. In addition,
large quantities of free fatty acids released from TG break-
down damage the pancreatic acinar cells and capillaries,
leading to a higher likelihood of SAP [20,21]. Further-
more, this result might also be related to the participation
of cholecystokinin, as some studies have shown that in
the presence of TG elevation, free fatty acids produced
in the body can strengthen the stimulation of cholecysto-
kinin on the excretion function of pancreatic acinar cells,
which subsequently activates the endoplasmic reticulum
stress phenomenon and thereby damages pancreatic aci-
nar cells [22].
This study also found that ABP patients with elevated
TG levels were more prone to organ failure, particularly
respiratory failure. In the AP disease course, respiratory
complications primarily include hypoxemia, acute respira-
tory distress syndrome, atelectasis, and pleural effusion.
Respiratory failure is largely due to the large number of
toxic cytokines produced during the AP disease course,
mainly including platelet-activating factor, TNF-α, IL-1,
IL-6, IL-8, NO, P substance, and macrophage-secreted cy-
tokines, which can cause systemic inflammatory response
syndrome and respiratory dysfunction. The reason why
ABP patients with elevated TG levels were more likely to
experience respiratory failure is related to the functions of
free fatty acids. In the presence of elevated TG, serum TG
is broken down under the action of lipoprotein lipase in
the lung, leading to the production of large quantities of
free fatty acids. Subsequently, free fatty acids dissociate
from albumin in the blood, enter the alveolar capillary
membrane, and destruct the pulmonary blood microcircu-
lation, leading to respiratory failure [23,24].
It remains unclear why some ABP patients show ele-
vated TG levels while others have normal TG levels, and
why the degree of elevated TG varies among patients. We
believe that this difference may be related to a number of
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patients may be associated with elevated TG levels and
the degree of such elevation. When the body has high
levels of fat, under the same level of stress and level of lip-
ase activity, the amount of involved fat tissue is increased,
and the amount of TG release is increased. In the present
study, the BMI of ABP patients with elevated TG levels
was significantly higher than that in patients with normal
TG levels. Indeed, previous studies have shown that obes-
ity is closely associated with AP aggravation, and some
scholars have suggested that obesity should be considered
an independent risk factor of AP aggravation, which is
consistent with the results of this study. In addition, in re-
cent years, some scholars have found that genetic polymor-
phisms are associated with the pathogenesis of AP with
HTG [25]. For example, Chang and his colleagues [26] first
reported that in HTG-induced AP patients, lipoprotein lip-
ase gene mutation was significantly increased, and the
probability of AP was 77.8% in patients with hyperlipid-
emia caused by the mutation in this gene. In short, there
may be a mutually reinforcing cycle between elevated TG
levels and pancreatitis, such that the occurrence of pan-
creatitis leads to elevated TG levels, which further increase
the severity of pancreatitis. This cycle may represent an-
other important vicious cycles in AP pathogenesis, and
timely blockade of this cycle may hold important signifi-
cance for reducing the degree of AP aggravation and im-
proving the efficacy and prognosis for patients with SAP.
The general treatment protocol of ABP was similar to
AP induced by other causes. At the outset, all patients
were treated in a conservative manner, and subsequently
so-called step-up approach was carried out [27,28].
Meanwhile, ERCP and EST were selectively performed
in some ABP patients, especially for patients with jaun-
dice and cholangitis. However, there were still controver-
sies on the indications and outcomes of ERCP and EST
in ABP treatment [29,30]. In the current study, no sig-
nificant difference of the frequencies of ERCP/EST was
observed between normal TG group and elevated TG
group. For patients with MSAP/SAP, the frequencies of
ERCP/EST were also not significantly different between
normal TG group and elevated TG group, but more pa-
tients in elevated TG group underwent PCD and open
necrosectomy. These results indicated that the ABP pa-
tients with TG elevation might be liable to undergo PCD
and open necrosectomy. However, as the patients were
divided into two groups according to the highest TG
level within 72 h of disease onset, we presumed that the
raised TG level might be responsible for the liability of
PCD and open necrosectomy.
Conclusions
In summary, when ABP is accompanied with TG elevation,
the risks of SAP and organ failure (especially respiratoryfailure) are significantly higher compared to patients with
normal TG levels. In particular, elevated TG levels and
pancreatitis may form a mutually reinforcing cycle, and
timely implementations of measures to block this vicious
cycle may hold important significance for reducing the rate
of AP aggravation and improving the treatment effects and
prognosis of SAP patients. Nevertheless, further research is
needed to reveal the pathophysiological mechanisms for
why elevated TG levels are present in ABP patients, as well
as the mechanism by which elevated TG cause injury to
specific tissues and organs.
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